what's more, the share price will rise towards the mid year in anticipation of the result of the Rett study. The current lag would appear to be due to a general sell-off (even much-fancied ADO is down) and the interest in a number of other biotechs at present. Nowabouts would seem quite a good time to buy, particularly given the lack of day trader interest at present.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.76 |
Change
0.170(1.17%) |
Mkt cap ! $1.837B | |||
| Open | High | Low | Value | Volume |
| $14.36 | $14.86 | $14.25 | $3.707M | 254.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $14.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.80 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |